Vegan Omegas + Vegan D3 II
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schizochytrium spp. Source : Huile de Schizochytrium Potency : 0 150-200 mg Docosahexaenoic acid | 500 mg | Not calculated |
| Schizochytrium spp. Source : Huile de Schizochytrium Potency : 0 75-150 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Schizochytrium spp. Source : Huile de Schizochytrium Potency : 0 250-300 mg EPA+DHA | Not specified | Not calculated |
Non-medicinal ingredients
Amidon de maïs, Caramel, Stéaryl fumarate de sodium, Lécithine, NA, Cellulose microcristalline, Extrait de fleur/ de feuilles/ de tige de Rosmarinus Officinalis (Romarin), Carraghénine, Palmitate d'ascorbyle, Glycérine, Lycopène, Huile de tournesol, Gélatine, Lécithine partiellement hydrolysées, Huile de son de riz, Sorbitol, Dioxyde de silicium, Huile de carthame, Huile de lin, Tocophérols, Cire d'abeille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps support/maintain eye health/function. Helps support/maintain visual health/function. Helps support/maintain brain function. Helps support/maintain (normal) heart/ cardiovascular health/function. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
Product record
- Other names
- Omega 3 + D3
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80066104
- Status
- Active licence
- Licence date
- 23 December 2015
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80066104
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vegan Omegas + Vegan D3 II (Advanced Orthomolecular Research Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80066104-vegan-omegas-vegan-d3-ii, updated 23 December 2015.